Strategic Financial Services Inc. Sells 24,213 Shares of SPDR S&P Biotech ETF $XBI

Strategic Financial Services Inc. cut its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 8.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 260,924 shares of the exchange traded fund’s stock after selling 24,213 shares during the quarter. SPDR S&P Biotech ETF accounts for about 1.5% of Strategic Financial Services Inc.’s investment portfolio, making the stock its 16th largest holding. Strategic Financial Services Inc. owned 0.39% of SPDR S&P Biotech ETF worth $32,749,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in the stock. Compass Wealth Management LLC purchased a new position in shares of SPDR S&P Biotech ETF in the third quarter worth approximately $1,167,000. China Universal Asset Management Co. Ltd. boosted its holdings in shares of SPDR S&P Biotech ETF by 868.3% in the third quarter. China Universal Asset Management Co. Ltd. now owns 4,919 shares of the exchange traded fund’s stock worth $493,000 after buying an additional 4,411 shares during the last quarter. Ashton Thomas Private Wealth LLC purchased a new position in shares of SPDR S&P Biotech ETF in the third quarter worth approximately $417,000. Banque Pictet & Cie SA boosted its holdings in shares of SPDR S&P Biotech ETF by 24.1% in the fourth quarter. Banque Pictet & Cie SA now owns 64,877 shares of the exchange traded fund’s stock worth $7,910,000 after buying an additional 12,595 shares during the last quarter. Finally, Apella Capital LLC purchased a new position in shares of SPDR S&P Biotech ETF in the fourth quarter worth approximately $490,000.

SPDR S&P Biotech ETF Trading Up 1.3%

XBI opened at $133.35 on Wednesday. The company has a market cap of $8.51 billion, a price-to-earnings ratio of 11.47 and a beta of 0.85. The company’s 50 day moving average is $130.23 and its 200 day moving average is $125.49. SPDR S&P Biotech ETF has a 12-month low of $78.06 and a 12-month high of $139.19.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.